Sign inJoin waitlistJoin the waitlist

Milan Anadkat

Director, Clinical Trials · Washington University/B-JH/SLCH Consortium

Credentials: · · ·

History

Washington University/B-JH/SLCH Consortium
Present

Dermatology
Barnes-Jewish Hospital
2004–2007
Washington University School of Medicine
2003–2004
Northeast Ohio Med Univ
1997–2001

Research

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update
Journal of Clinical Oncology · 2021 · 1,863 citations
Management of Immune-Related Adverse Events in Patients Treated With Chimeric Antigen Receptor T-Cell Therapy: ASCO Guideline
Systematic review or meta-analysis · Journal of Clinical Oncology · 2021 · 364 citations
First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation
Blood · 2018 · 345 citations

Mario Lacouture
13 papers · 5 as a resident
IR
Ilana Rosman
7 papers · 2 as a resident
Amy Musiek
6 papers
Cynthia Wang
6 papers · 2 as a resident
Mark Lebwohl
6 papers
Benjamin Kaffenberger
5 papers
DH
Donna Hepper
5 papers · 5 as a resident
MH
Michael Heffernan
4 papers
Peggy Wu
4 papers · 3 as a resident
Alejandro Gru
3 papers · 1 as a fellow
EC
Edward Cowen
3 papers
Kenneth Gordon
3 papers

Clinical trials

Safety, Tolerability and Systemic Absorption of Menadione Topical Lotion for Epidermal-Growth-Factor-Receptor (EGFR) Inhibitor-Associated Rash
Principal investigator · Completed · Phase 1
Spectrum Pharmaceuticals, Inc
2008–2009